Please upgrade your Flash Player

Latest Update: Monday, October, 13th 2008

Search Site


Directs the Louisiana Board of Pharmacy to convene its Regulation Revision Committee to consider changes to the rules and regulations of the board to expressly prohibit a pharmacist from interchanging an anti-epileptic drug for the treatment of epilepsy without the prior notification of both the prescribing physician and the patient
Latest Actions
  • 05/27/2008 - Read by title, under the rules, referred to the Committee on Health and Welfare.
  • 05/22/2008 - HCR154: Read by title. Lies over under the rules.
Bill Text
File name Last Updated
HCR154 Text06/18/2008

Fiscal Notes
File name Last Updated
HCR154 Fiscal Notes06/18/2008